SECsense Logo

Dexcom, Inc. 8-K Report: Key Updates & Insights for Investors

$DXCM
Form 8-K
Filed on: 2025-02-13
Source
Dexcom, Inc. 8-K Report: Key Updates & Insights for Investors

Based on the provided section of the financial report, here are the key details extracted:

  1. Entity Information:
  • Company Name: Dexcom, Inc.
  • CIK Number: 0001093557
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 000-51222
  • IRS Employer Identification Number: 33-0857544
  1. Contact Information:
  • Address: 6340 Sequence Drive, San Diego, CA 92121
  • Phone Number: 858-200-0200
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 13, 2025
  1. Stock Information:
  • Type of Security: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: DXCM
  • Exchange: NASDAQ
  1. Reporting Period:
  • Date of Report: February 13, 2025
  • This report is for a specific date rather than a range, indicating it likely contains significant events or changes that occurred on that date.

Insights:

  • The filing is an 8-K, which typically reports unscheduled material events or corporate changes, suggesting that the information disclosed may be of high importance to investors.
  • The report pertains to Dexcom, a company that is likely involved in the medical technology sector, given its focus on continuous glucose monitoring products.
  • The report's date being in the future (February 13, 2025) could imply that this is a preliminary filing for events anticipated to occur or be disclosed on that date.

This information is crucial for stakeholders, including investors and analysts, as it may impact stock prices and investment decisions related to Dexcom, Inc.